4-(((2S,4R)-7-guanidino-3-oxo-4-(phenylmethylsulfonamido)heptan-2-ylamino)methyl)benzimidamide

ID: ALA1809254

Chembl Id: CHEMBL1809254

PubChem CID: 56659850

Max Phase: Preclinical

Molecular Formula: C23H33N7O3S

Molecular Weight: 487.63

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@H](NCc1ccc(C(=N)N)cc1)C(=O)[C@@H](CCCNC(=N)N)NS(=O)(=O)Cc1ccccc1

Standard InChI:  InChI=1S/C23H33N7O3S/c1-16(29-14-17-9-11-19(12-10-17)22(24)25)21(31)20(8-5-13-28-23(26)27)30-34(32,33)15-18-6-3-2-4-7-18/h2-4,6-7,9-12,16,20,29-30H,5,8,13-15H2,1H3,(H3,24,25)(H4,26,27,28)/t16-,20+/m0/s1

Standard InChI Key:  URPPDOVITGWCNB-OXJNMPFZSA-N

Associated Targets(Human)

TMPRSS11D Tchem Transmembrane protease serine 11D (59 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F2 Tclin Thrombin (11687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F10 Tclin Coagulation factor X (9693 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLG Tclin Plasminogen (2339 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 487.63Molecular Weight (Monoisotopic): 487.2366AlogP: 0.77#Rotatable Bonds: 14
Polar Surface Area: 187.04Molecular Species: BASEHBA: 6HBD: 7
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 9#RO5 Violations (Lipinski): 1
CX Acidic pKa: 8.62CX Basic pKa: 12.04CX LogP: 0.24CX LogD: -3.41
Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.12Np Likeness Score: -0.61

References

1. Sielaff F, Böttcher-Friebertshäuser E, Meyer D, Saupe SM, Volk IM, Garten W, Steinmetzer T..  (2011)  Development of substrate analogue inhibitors for the human airway trypsin-like protease HAT.,  21  (16): [PMID:21741839] [10.1016/j.bmcl.2011.06.033]

Source